The results from SELECT will be instrumental in changing the way we perceive and treat obesity. Exploring data on the cardiovascular impact of weekly semaglutide treatments from the SELECT trial SELECT enrolled more than 17,000 patients with pre-existing cardiovascular disease who were overweight or obese, but did not present with diabetes
The future of GLP-1 dosing The dosing landscape is evolving rapidly
And that's how all these new generation medications work by reducing appetite, which leads to reducing caloric intake, which then leads to losing body weight
This article will compare two common weight loss drugs, Contrave and phentermine, to help you identify their similarities and differences to decide if one might be the right option for you
Phenoxyethanol: A preservative that stops bacteria and mold from growing in your moisturizer
Is Retatrutide a Better Drug for Weight Loss